Manejo respiratório em doenças neuromusculares: revisão de literatura
DOI:
https://doi.org/10.29237/2358-9868.2017v5i2.p121-129Resumo
Objetivo: Descrever o acometimento respiratório em doenças neuromusculares e tratamentos disponíveis para suporte ventilatório em tais patologias. Métodos: Levantamento bibliográfico de artigos científicos pesquisados em bases de dados (Capes, Pubmed e SciELO) e artigos/ capítulos de livros disponíveis em http://www.doctorbach.com. Resultados: foram selecionados e revisados 37 artigos/ capítulos relacionados à insuficiência ventilatória em doenças neuromusculares e seu manejo. Conclusão: Há evidências da literatura indicando a utilização da ventilação não invasiva neste grupo de pacientes, com intuito de melhora da troca gasosa, alívio da dispnéia, descanso à musculatura inspiratória, redução da incidência de infecções nosocomiais, internações e mortalidade.Referências
1. Misuri G, Lanini B, Gigliotti F, Iandelli I, Pizzi A, Bertolini MG, et al. Mechanism of CO2 retention in patients with neuromuscular disease. Chest 2000; 117:447-53.
2. Baydur A, Gilgoff I, Prentice W, Carlson M, Fischer DA. Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne’s muscular dystrophy. Chest 1990; 97:8849.
3. Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130:1879-86.
4. Rochester DF, Esau SA. Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 1994; 15:751-63.
5. Han Eol Cho, Jang Woo Lee, Seong Woong Kang, Won Ah Choi, Hyeonjun Oh, Kil Chan Lee. Comparison of Pulmonary Functions at Onset of Ventilatory Insufficiency in Patients With Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, and Myotonic Muscular Dystrophy. Ann Reahabil Med 2016; 40 (1): 74-80.
6. Perrin C, Unterborn JN, Ambrosio CD, et al. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004; 29: 5–27.
7. Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database Syst Rev 2004; 2: CD004303.
8. Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 2009; 34: 444–451.
9. Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000; 29: 141–150.
10. Polkey MI, Lyall RA, Green M, et al. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998; 158: 734–741.
11. Culebras A. Sleep and neuromuscular disorders. Neurol Clin 2005; 23: 1209–1223.
12. Schneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002; 20: 480–487.
13. Ono S, Takahashi K, Kanda F, et al. Decrease of neurons in the medullary arcuate nucleus in myotonic dystrophy. Acta Neuropathol 2001; 102: 89–93.
14. Stephen C Bourke. Respiratory involvement in neuromuscular disease. Clinical Medicine. 2014 Vol 14, No 1: 72–5.
15. Farreroa E, Antónb A, Egeac CJ, Almarazd MJ, Masae JF, Utrabo I, et al. Guidelines for the Management of Respiratory Complications in Patients With Neuromuscular Disease. Arch. Bronconeumol. 2013;49(7):306–313.
16. American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624.
17. Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719-27.
18. Black LF, Hyatt RE. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis. 1971;103(5):641-50.
19. Caruso P, Albuquerque ALP, Santana PV, Cardenas LZ, Ferreira JG, Prina E, et al. Métodos diagnósticos para avaliação da força muscular inspiratória e expiratória. J Bras Pneumol. 2015;41(2):110-123.
20. Koulouris N, Vianna LG, Mulvey DA, Green M, Moxham J. Maximal relaxation rates of esophageal, nose, and mouth pressures during a sniff reflect inspiratory muscle fatigue. Am Rev Respir Dis. 1989;139(5):1213-7.
21. Héritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure. A noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1678-83.
22. Uldry C, Fitting JW. Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax. 1995;50(4):371-5.
23. Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1507-11.
24. Bach J, Gonçalves MR. Protocolos de ajudas técnicas aos músculos respiratórios para evitar falência respiratória e traqueostomia: um novo paradigma de tratamento para os pacientes com doença neuromuscular. In: George Sarmento. Recursos em Fisioterapia Cardiorespiratória. 1ª ed. Editora Manole; 2012; Pags 314-328.
25. Bach JR. Management of Pacients with Neuromuscular Disease. Philadelphia, Hanley & Belfus 2004; 155 - 299.
26. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010; 9: 177–189.
27. Phillips MF, Quinlivan RC, Edwards RH, et al. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001; 164: 2191–2194.
28. Florian Stehling, Anastasios Bouikidis, Ulrike Schara and Uwe Mellies. Mechanical insufflation/exsufflation improves vital capacity in neuromuscular disorders. Chronic Respiratory Disease 2014; 1-5.
29. Bach JR, Gonçalves MR. Avanços em Doenças Neuromusculares e Lesões Vértebro-medulares. Rev Port Pneumo. 2006; Volume 12, Issue 1, Supplement 1, Pages S5–S65.
30. Joshua O, Benditt and Louis J. Boitano. Pulmonary Issues in Patients with Chronic Neuromuscular Disease. Am J Respir Crit Care Med. 2013; Vol 187, Iss. 10, pp 1046–1055.
31. Nicolini A, Russo D, Barlascini CO, Sclifò F, Grecchi B, Garuti GC, et al. Mouthpiece Ventilation in Patients with Neuromuscular Disease: A Brief Clinical Review. Phys Med Rehabil Int. 2014;1(3): 4.
32. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170: 456–465.
33. Ishikawa Y, Miura T, Aoyagi T, et al. Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul Disord 2011; 21: 47–51.
34. Bach JR. Respiratory muscle aids: patient evaluation, respiratory aid protocol, and outcomes. In: Bach JR, ed. The Management of Patients with Neuromuscular Disease. Philadelphia, Hanley and Belfus, 2004: pp. 271–308.
35. McKim DA, Katz SL, Barrowman N, et al. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy. Arch Phys Med Rehabil 2012; 93: 1117–1122.
36. Gomez-Merino and Bach JR. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 2002; 81: 411–415.
2. Baydur A, Gilgoff I, Prentice W, Carlson M, Fischer DA. Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne’s muscular dystrophy. Chest 1990; 97:8849.
3. Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130:1879-86.
4. Rochester DF, Esau SA. Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 1994; 15:751-63.
5. Han Eol Cho, Jang Woo Lee, Seong Woong Kang, Won Ah Choi, Hyeonjun Oh, Kil Chan Lee. Comparison of Pulmonary Functions at Onset of Ventilatory Insufficiency in Patients With Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, and Myotonic Muscular Dystrophy. Ann Reahabil Med 2016; 40 (1): 74-80.
6. Perrin C, Unterborn JN, Ambrosio CD, et al. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004; 29: 5–27.
7. Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database Syst Rev 2004; 2: CD004303.
8. Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 2009; 34: 444–451.
9. Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000; 29: 141–150.
10. Polkey MI, Lyall RA, Green M, et al. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998; 158: 734–741.
11. Culebras A. Sleep and neuromuscular disorders. Neurol Clin 2005; 23: 1209–1223.
12. Schneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002; 20: 480–487.
13. Ono S, Takahashi K, Kanda F, et al. Decrease of neurons in the medullary arcuate nucleus in myotonic dystrophy. Acta Neuropathol 2001; 102: 89–93.
14. Stephen C Bourke. Respiratory involvement in neuromuscular disease. Clinical Medicine. 2014 Vol 14, No 1: 72–5.
15. Farreroa E, Antónb A, Egeac CJ, Almarazd MJ, Masae JF, Utrabo I, et al. Guidelines for the Management of Respiratory Complications in Patients With Neuromuscular Disease. Arch. Bronconeumol. 2013;49(7):306–313.
16. American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624.
17. Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719-27.
18. Black LF, Hyatt RE. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis. 1971;103(5):641-50.
19. Caruso P, Albuquerque ALP, Santana PV, Cardenas LZ, Ferreira JG, Prina E, et al. Métodos diagnósticos para avaliação da força muscular inspiratória e expiratória. J Bras Pneumol. 2015;41(2):110-123.
20. Koulouris N, Vianna LG, Mulvey DA, Green M, Moxham J. Maximal relaxation rates of esophageal, nose, and mouth pressures during a sniff reflect inspiratory muscle fatigue. Am Rev Respir Dis. 1989;139(5):1213-7.
21. Héritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure. A noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1678-83.
22. Uldry C, Fitting JW. Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax. 1995;50(4):371-5.
23. Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1507-11.
24. Bach J, Gonçalves MR. Protocolos de ajudas técnicas aos músculos respiratórios para evitar falência respiratória e traqueostomia: um novo paradigma de tratamento para os pacientes com doença neuromuscular. In: George Sarmento. Recursos em Fisioterapia Cardiorespiratória. 1ª ed. Editora Manole; 2012; Pags 314-328.
25. Bach JR. Management of Pacients with Neuromuscular Disease. Philadelphia, Hanley & Belfus 2004; 155 - 299.
26. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010; 9: 177–189.
27. Phillips MF, Quinlivan RC, Edwards RH, et al. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001; 164: 2191–2194.
28. Florian Stehling, Anastasios Bouikidis, Ulrike Schara and Uwe Mellies. Mechanical insufflation/exsufflation improves vital capacity in neuromuscular disorders. Chronic Respiratory Disease 2014; 1-5.
29. Bach JR, Gonçalves MR. Avanços em Doenças Neuromusculares e Lesões Vértebro-medulares. Rev Port Pneumo. 2006; Volume 12, Issue 1, Supplement 1, Pages S5–S65.
30. Joshua O, Benditt and Louis J. Boitano. Pulmonary Issues in Patients with Chronic Neuromuscular Disease. Am J Respir Crit Care Med. 2013; Vol 187, Iss. 10, pp 1046–1055.
31. Nicolini A, Russo D, Barlascini CO, Sclifò F, Grecchi B, Garuti GC, et al. Mouthpiece Ventilation in Patients with Neuromuscular Disease: A Brief Clinical Review. Phys Med Rehabil Int. 2014;1(3): 4.
32. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170: 456–465.
33. Ishikawa Y, Miura T, Aoyagi T, et al. Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul Disord 2011; 21: 47–51.
34. Bach JR. Respiratory muscle aids: patient evaluation, respiratory aid protocol, and outcomes. In: Bach JR, ed. The Management of Patients with Neuromuscular Disease. Philadelphia, Hanley and Belfus, 2004: pp. 271–308.
35. McKim DA, Katz SL, Barrowman N, et al. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy. Arch Phys Med Rehabil 2012; 93: 1117–1122.
36. Gomez-Merino and Bach JR. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 2002; 81: 411–415.
Downloads
Publicado
2017-12-18
Edição
Seção
REVISÃO DE LITERATURA
